We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 22, 2018

SGLT2 Inhibitors Associated With Lower-Extremity Amputation Among Patients With Type 2 Diabetes

JAMA internal medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA internal medicine
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes
JAMA Intern Med 2018 Aug 13;[EPub Ahead of Print], HY Chang, S Singh, O Mansour, S Baksh, GC Alexander

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading